
### [NCIT:C4454](http://purl.obolibrary.org/obo/NCIT_C4454)
**Label:** Benign Lung Neoplasm

**Subclasses:** [NCIT:C5657](http://purl.obolibrary.org/obo/NCIT_C5657) (Lung Myolipoma), [NCIT:C5658](http://purl.obolibrary.org/obo/NCIT_C5658) (Lung Fibroma), [NCIT:C5664](http://purl.obolibrary.org/obo/NCIT_C5664) (Lung Mucous Gland Adenoma), [NCIT:C4455](http://purl.obolibrary.org/obo/NCIT_C4455) (Lung Adenoma), [NCIT:C5660](http://purl.obolibrary.org/obo/NCIT_C5660) (Lung Leiomyoma), [NCIT:C5661](http://purl.obolibrary.org/obo/NCIT_C5661) (Endobronchial Leiomyoma), [NCIT:C133091](http://purl.obolibrary.org/obo/NCIT_C133091) (Lung Adenofibroma), [NCIT:C45601](http://purl.obolibrary.org/obo/NCIT_C45601) (Lung Glandular Papilloma), [NCIT:C5063](http://purl.obolibrary.org/obo/NCIT_C5063) (Endobronchial Lipoma), [NCIT:C45603](http://purl.obolibrary.org/obo/NCIT_C45603) (Lung Pleomorphic Adenoma), [NCIT:C3494](http://purl.obolibrary.org/obo/NCIT_C3494) (Lung Papillary Adenoma), [NCIT:C4140](http://purl.obolibrary.org/obo/NCIT_C4140) (Alveolar Adenoma), [NCIT:C45604](http://purl.obolibrary.org/obo/NCIT_C45604) (Lung Mucinous Cystadenoma), [NCIT:C8295](http://purl.obolibrary.org/obo/NCIT_C8295) (Lung Papilloma), [NCIT:C45629](http://purl.obolibrary.org/obo/NCIT_C45629) (Lung Chondroma), 

**Class expressions from DL-Learner:**

- Thing 52.53%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40015](http://purl.obolibrary.org/obo/NCIT_C40015) (Ovarian Mucinous Carcinoid Tumor))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40014](http://purl.obolibrary.org/obo/NCIT_C40014) (Ovarian Trabecular Carcinoid Tumor))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39991](http://purl.obolibrary.org/obo/NCIT_C39991) (Non-Gestational Ovarian Choriocarcinoma))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39989](http://purl.obolibrary.org/obo/NCIT_C39989) (Ovarian Yolk Sac Tumor, Hepatoid Pattern))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39988](http://purl.obolibrary.org/obo/NCIT_C39988) (Ovarian Yolk Sac Tumor, Glandular Pattern))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39985](http://purl.obolibrary.org/obo/NCIT_C39985) (Ovarian Gonadoblastoma))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C3998](http://purl.obolibrary.org/obo/NCIT_C3998) (Recurrent Colon Carcinoma))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39966](http://purl.obolibrary.org/obo/NCIT_C39966) (Ovarian Sertoli-Stromal Cell Tumor))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39963](http://purl.obolibrary.org/obo/NCIT_C39963) (Penile Bowenoid Papulosis))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39961](http://purl.obolibrary.org/obo/NCIT_C39961) (Penile Basal Cell Carcinoma))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39959](http://purl.obolibrary.org/obo/NCIT_C39959) (Mixed Squamous Cell Carcinoma of the Penis))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39957](http://purl.obolibrary.org/obo/NCIT_C39957) (Epididymal Adenocarcinoma))) 40.36%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39956](http://purl.obolibrary.org/obo/NCIT_C39956) (Rete Testis Adenoma))) 40.36%


